BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 32624383)

  • 21. Role of Ancillary Techniques in Cervical Biopsy and Endocervical Curettage Specimens as Follow-Up to Papanicolaou Test Results Indicating a Diagnosis of Atypical Squamous Cells, Cannot Exclude High-Grade Squamous Intraepithelial Lesion, or High-Grade Squamous Intraepithelial Lesion.
    Jenkins TM; Shojaei H; Song SJ; Schwartz LE
    Acta Cytol; 2020; 64(1-2):155-165. PubMed ID: 30982025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of cobas 4800 HPV assay in SurePath Papanicolaou specimens for cervical cancer screening.
    Guo M; Shlyakhova N; Khanna A; Tinnirello AA; Schmeler KM; Hwang J; Sturgis EM; Stewart J
    J Am Soc Cytopathol; 2021; 10(4):399-405. PubMed ID: 33967024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The increased detection of cervical intraepithelial neoplasia when using a second biopsy at colposcopy.
    van der Marel J; van Baars R; Rodriguez A; Quint WG; van de Sandt MM; Berkhof J; Schiffman M; Torné A; Ordi J; Jenkins D; Verheijen RH; Helmerhorst TJ; Ter Harmsel B; Wentzensen N; Del Pino M
    Gynecol Oncol; 2014 Nov; 135(2):201-7. PubMed ID: 25204846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endocervical glandular involvement is associated with an increased detection rate of high-grade squamous intraepithelial lesions on the Papanicolaou test.
    Jones R; Dale F; Fite JJ; Cowan ML; Williamson B; DeLuca J; VandenBussche CJ
    J Am Soc Cytopathol; 2020; 9(3):137-145. PubMed ID: 32147423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the diagnostic value of cervical cytology and HPV HR DNA testing for the diagnosis of low-grade and high-grade squamous intraepithelial lesions across different age groups.
    Paluszkiewicz A; Pruski D; Iwaniec K; Kędzia W
    Ginekol Pol; 2017; 88(3):141-146. PubMed ID: 28397203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A retrospective analysis on 1901 women with high grade cervical intraepithelial neoplasia by colposcopic biopsy.
    Zhang X; Dou Y; Wang M; Li Y; Wang F; Xie X; Wang X
    Eur J Obstet Gynecol Reprod Biol; 2017 Oct; 217():53-58. PubMed ID: 28850822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cervical Papanicolaou tests in the female-to-male transgender population: should the adequacy criteria be revised in this population? An Institutional Experience.
    Plummer RM; Kelting S; Madan R; O'Neil M; Dennis K; Fan F
    J Am Soc Cytopathol; 2021; 10(3):255-260. PubMed ID: 33736951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The newly proposed International Endocervical Adenocarcinoma Criteria and Classification and its relevance to cervical cytology screening assessed in a prospective 2-year study of 118 cases.
    Ondič O; Němcová J; Alaghehbandan R; Černá K; Gomolčáková B; Kinkorová-Luňáčková I; Chytra J; Šidlová H; Hósová M; Bouda J
    Cytopathology; 2020 Jul; 31(4):288-291. PubMed ID: 32289186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rescreening of high-risk HPV positive Papanicolaou tests initially screened as negative is a low yield procedure in the era of HPV genotyping.
    Narkcham S; Mody DR; Jones A; Thrall MJ
    J Am Soc Cytopathol; 2021; 10(6):558-564. PubMed ID: 34103275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced Detection of Cervical Cancer and Precancer Through Use of Imaged Liquid-Based Cytology in Routine Cytology and HPV Cotesting.
    Austin RM; Onisko A; Zhao C
    Am J Clin Pathol; 2018 Oct; 150(5):385-392. PubMed ID: 30137189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presence of 10 transformation zone cells in endocervical curettage should not be required for adequacy.
    Alqabbani R; Chan J; Goldberg A
    Am J Clin Pathol; 2024 Apr; 161(4):369-373. PubMed ID: 38035727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HPV RNA in situ hybridization can inform cervical cytology-histology correlation.
    Coppock JD; Willis BC; Stoler MH; Mills AM
    Cancer Cytopathol; 2018 Aug; 126(8):533-540. PubMed ID: 29975461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity, and cost-effectiveness.
    Kaufman RH; Adam E; Icenogle J; Reeves WC
    Am J Obstet Gynecol; 1997 Oct; 177(4):930-6. PubMed ID: 9369847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-grade squamous intraepithelial lesion on Papanicolaou test: follow-up rates and stratification of risk for high-grade squamous intraepithelial lesion.
    Rufail M; Lew M; Pang J; Jing X; Heider A; Cantley RL
    J Am Soc Cytopathol; 2020; 9(4):258-265. PubMed ID: 32402830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Precancerous lesions of the uterine cervix: morphology and molecular pathology].
    Horn LC; Klostermann K
    Pathologe; 2011 Nov; 32 Suppl 2():242-54. PubMed ID: 21909794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating cytology for the detection of invasive cervical cancer.
    Landy R; Castanon A; Hamilton W; Lim AW; Dudding N; Hollingworth A; Sasieni PD
    Cytopathology; 2016 Jun; 27(3):201-9. PubMed ID: 26126636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical performance of the aptima HPV assay in 4196 women with positive high-risk HPV and ASC-US cytology: A large women hospital experience.
    Wang T; Pradhan D; Zhang H; Matsko J; Zhao C
    Diagn Cytopathol; 2021 Jan; 49(1):5-10. PubMed ID: 32857920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can the careHPV test performed in mobile units replace cytology for screening in rural and remote areas?
    Lorenzi AT; Fregnani JH; Possati-Resende JC; Antoniazzi M; Scapulatempo-Neto C; Syrjänen S; Villa LL; Longatto-Filho A
    Cancer Cytopathol; 2016 Aug; 124(8):581-8. PubMed ID: 27070446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program.
    Loopik DL; Koenjer LM; Siebers AG; Melchers WJG; Bekkers RLM
    Am J Obstet Gynecol; 2021 Feb; 224(2):200.e1-200.e9. PubMed ID: 32800820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel techniques for morphometric and geometrical analysis in squamous intraepithelial lesions on cervical smears.
    Tsiambas E; Riziotis C; Mavrikos I; Armatas E; Patsouris E
    J BUON; 2017; 22(4):1081-1083. PubMed ID: 28952232
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.